Flow cytometric analysis of glyoxalase-1 expression in human leukocytes

Cell Biochemistry and Function

Volumn 29, Issue 2, 2011, Pages 171-174

  Skapare, Elina ^a,b   Riekstina, Una ^c   Liepinsh, Edgars ^a   Konrade, Ilze ^b   Makrecka, Marina ^a,b   Maurina, Baiba ^b   Dambrova, Maija ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Flow cytometry; Glyoxalase 1; Late complications of diabetes mellitus; Leukocytes

Indexed keywords

GLYOXALASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; ISOLATION AND PURIFICATION; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; MONONUCLEAR CELL; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LACTOYLGLUTATHIONE LYASE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79952220703     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1723     Document Type: Article

References (19)

1. Thornalley PJ. Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor. Crit Rev Oncol Hematol 1995; 20: 99-128.
2. Thornalley PJ. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabol Drug Interact 2008; 23: 125-150.
3. Miyata T, van Ypersele de Strihou C, Imasawa T, et al. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney Int 2001; 60: 2351-2359.
4. Thornalley PJ. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J 1988; 254: 751-755.
5. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 1994; 87: 21-29.
6. Thornalley PJ, Hooper NI, Jennings PE, et al. The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Res Clin Pract 1989; 7: 115-120.
7. Ratliff DM, Vander Jagt DJ, Eaton RP, Vander Jagt DL. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II-a clinical research center study. J Clin Endocrinol Metab 1996; 81: 488-492.
8. Thornalley PJ, Bellavite P. Modification of the glyoxalase system during the functional activation of human neutrophils. Biochim Biophys Acta 1987; 931: 120-129.
9. Basu S, Campbell HM, Dittel BN, Ray A. Purification of specific cell population by fluorescence activated cell sorting (FACS). J Vis Exp 2010; 41: DOI: 10.3791/1546.
10. Pandzic JV, Gizdic B, Miletic Z, Ostovic KT, Jaksic O. Monocytes in metabolic disorders-opportunities for flow cytometry contributions. Coll Antropol 2010; 34: 319-325.
11. Moore GL, Ledford ME, Merydith A. A micromodification of the Drabkin hemoglobin assay for measuring plasma hemoglobin in the range of 5-2000mg/dl. Biochem Med 1981; 26: 167-173.
12. Miller AG, Smith DG, Bhat M, Nagaraj RH. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem 2006; 281: 11864-11871.
13. Staniszewska MM, Nagaraj RH. Upregulation of glyoxalase I fails to normalize methylglyoxal levels: a possible mechanism for biochemical changes in diabetic mouse lenses. Mol Cell Biochem 2006; 288: 29-36.
14. Vander Jagt DL, Hunsaker LA. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact 2003; 143-144: 341-351.
15. Miyamoto K, Ogura Y, Kenmochi S, Honda Y. Role of leukocytes in diabetic microcirculatory disturbances. Microvasc Res 1997; 54: 43-48.
16. Otton R, Mendonca JR, Curi R. Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol 2002; 174: 55-61.
17. Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 1999; 42: 603-607.
18. Deopurkar R, Ghanim H, Friedman J, et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 2010; 33: 991-997.
19. Wu HP, Kuo SF, Wu SY, Chuang DY. High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients. Cytokine 2010; 51: 298-304.